Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Yang, J.; Fullmer, B.; Harro, C.; Lowy, D. R.; Lempicki, R. A.; Pinto, L. A.
  3. Journal of Immunology. 2009 182(3): 1706-1729.
  1. 2.   Pol-specific CD8(+) T cells recognize simian immunodeficiency virus-infected cells prior to nef-mediated major histocompatibility complex class I Downregulation
  2. Sacha, J. B.; Chung, C.; Reed, J.; Jonas, A. K.; Bean, A. T.; Spencer, S. P.; Lee, W.; Vojnov, L.; Rudersdorfl, R.; Friedrich, T. C.; Wilson, N. A.; Lifson, J. D.; Watkins, D. I.
  3. Journal of Virology. 2007, Nov; 81(21): 11703-11712.
  1. 3.   Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid
  2. Boyer, J. D.; Robinson, T. M.; Kutzler, M. A.; Vansant, G.; Hokey, D. A.; Kumar, S.; Parkinson, R.; Wu, L.; Sidhu, M. K.; Pavlakis, G. N.; Felber, B. K.; Brown, C.; Silvera, P.; Lewis, M. G.; Monforte, J.; Waldmann, T. A.; Eldridge, J.; Weiner, D. B.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Nov; 104(47): 18648-18653.
  1. 4.   Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles
  2. Garcia-Pineres, A.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Williams, M.; Harro, C.; Lowy, D. R.; Schiller, J. T.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2007, Aug; 14(8): 984-989.
  1. 5.   A dose sparing effect by plasmid encoded IL-12 adjuvant on a SlVgag-plasmid DNA vaccine in rhesus macaques
  2. Schadeck, E. B.; Sidhu, M.; Egan, M. A.; Chong, S. Y.; Piacente, P.; Masood, A.; Garcia-H, D.; Cappello, S.; Roopch, V.; Megati, S.; Quiroz, J.; Boyer, J. D.; Felber, B. K.; Pavlakis, G. N.; Weiner, D. B.; Eldridge, J. H.; Israel, Z. R.
  3. Vaccine. 2006, May; 24(21): 4677-4687.
  1. 6.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
  1. 7.   HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood
  2. Pinto, L. A.; Castle, P. E.; Roden, R. B.; Harro, C. D.; Lowy, D. R.; Schiller, J. T.; Wallace, D.; Williams, M.; Kopp, W.; Frazer, I. H.; Berzofsky, J. A.; Hildesheim, A.
  3. Vaccine. 2005, MAY 20; 23(27): 3555-3564.
  1. 8.   Reversion of CTL escape-variant immunodeficiency viruses in vivo
  2. Friedrich, T. C.; Dodds, E. J.; Yant, L. J.; Vojnov, L.; Rudersdorf, R.; Cullen, C.; Evans, D. T.; Desrosiers, R. C.; Mothe, B. R.; Sidney, J.; Sette, A.; Kunstman, K.; Wolinsky, S.; Piatak, M.; Lifson, J.; Hughes, A. L.; Wilson, N.; O'Connor, D. H.; Watkins, D. I.
  3. Nature Medicine. 2004 10(3): 275-281.
  1. 9.   Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIVmac251 challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen
  2. Zhao, J.; Pinczewski, J.; Gomez-Roman, V. R.; Venzon, D.; Kalyanaraman, V. S.; Markham, P. D.; Aldrich, K.; Moake, M.; Montefiori, D. C.; Lou, Y. M.; Pavlakis, G. N.; Robert-Guroff, M.
  3. Journal of Virology. 2003 77(15): 8354-8365.
  1. 10.   Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes
  2. Hel, Z.; Tryniszewska, E.; Tsai, W. P.; Johnson, J. M.; Harrod, R.; Fullen, J.; Kalyanaraman, V. S.; Altman, J. D.; McNally, J.; Karpova, T.; Felber, B. K.; Tartaglia, J.; Franchini, G.
  3. DNA and Cell Biology. 2002 21(9): 619-626.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel